Clinical Trial Update: Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial updates the combination of pembrolizumab and interferon-gamma for various mycosis fungoides/Sezary syndrome and synovial sarcoma conditions; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Synovial Sarcoma
• Sézary Syndrome

Drugs mentioned

• Interferon-gamma (interferon gamma)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma | Phase 2 | Status: COMPLETED | Results posted: 2022-08-30